2021 ESC/EACTS Guidelines for management of valvular heart disease- Aortic stenosis
Medical Dialogues interacts with Dr O P Yadava, a Cardiothoracic surgeon who has given his expert insights on the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery guidelines.
Aortic stenosis (AS) is a common valvular heart disease, with an estimated overall prevalence of 3% in adults over 75 years. Aortic stenosis is the most frequent, single, native left-sided valve disease comprising of 43%. Aortic stenosis is the most common primary valve lesion requiring surgery or transcatheter intervention and its prevalence is rising rapidly as a consequence of the ageing population.
Now, the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery guidelines have covered the evaluation parameters, the diagnostic workup involved, the indications for intervention- be it either TAVI or the Surgical AVR procedure and about the medical therapy.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.